PhaseV is a Boston-based technology company transforming clinical development with an enterprise-ready AI/ML platform that accelerates decisions, de-risks trials, and drives portfolio efficiency. Its Trial Optimizer designs smarter studies, reducing costs by up to 50%, lowering enrollment needs by 40%, shortening timelines by 40%, and boosting probability of success by 30%+. The ClinOps Optimizer enhances site selection by integrating patient-level insights with real-time dashboards to track performance. The Lifecycle Management module combines causal evidence, development complexity, and market value to inform portfolio decisions. Together, these solutions enable sponsors and CROs to optimize every stage of development.
| Website | https://www.phasevtrials.com/ |
| Employees | 66 (45 on RocketReach) |
| Address | 1 Broadway, Cambridge, Massachusetts 02142, US |
| Industry | Biotechnology Research |
| Keywords | Clinical Trial Optimization, Clinical Trial Automation, Clinical Trial Efficiency, Clinical Trial Technology, Clinical Trial Analytics, Pharmaceutical Technology, Biotech Technology |
| Competitors | Oracle, Research Pharmaceutical Services, ICON plc, Veeva Systems, Syneos Health, Parexel, Medidata Solutions, Covance, Celerion, PharmaSeek +32 more (view full list) |
Looking for a particular PhaseV employee's phone or email?
PhaseV Questions
Raviv Pryluk is the CEO and Co-Founder of PhaseV.
45 people are employed at PhaseV.
PhaseV is based in Cambridge, Massachusetts.
Top PhaseV Employees
-
Raviv Pryluk
CEO and Co-Founder at PhaseV
United States21 -
31
-
33
-
Alex Kremer
VP Finance and Operations at PhaseV
Boston, MA, US44 -
Adam Brown
Head of Alliance Management at PhaseV
Watertown, MA, US32 -
Carles Monterrubio
Director, Partnering at PhaseV
Cambridge, MA, US41 -
Amir Mehler
Head of DevOps at PhaseV
Tel Aviv District, Israel21 -
41
-
11
-
Netta Koren
Principal Product Manager at PhaseV
Boston, MA, US2
